Dimethylaminoethanol Bitartrate Production Cost Reports

The report provides a detailed analysis essential for establishing a Dimethylaminoethanol Bitartrate production plant. It encompasses all critical aspects necessary for Dimethylaminoethanol Bitartrate production, including the cost of Dimethylaminoethanol Bitartrate production, Dimethylaminoethanol Bitartrate plant cost, Dimethylaminoethanol Bitartrate production costs, and the overall Dimethylaminoethanol Bitartrate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Dimethylaminoethanol Bitartrate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Dimethylaminoethanol bitartrate (DMAE bitartrate) is a stabilised salt form of the base compound dimethylaminoethanol (DMAE). It is utilised in pharmaceutical and nutraceutical production as an important intermediate for synthesising amino acids such as tryptophan and phenylalanine. It is also used in the synthesis of protein sugars and vitamin B derivatives, due to its enhanced solubility and stability for large-scale biochemical production under GMP conditions. Additionally, the parent DMAE compound finds uses in curing agents for polyurethane foams and epoxy resins, in water treatment flocculants, and roles in corrosion inhibitors, as well as emulsifiers for water-based paints, dyes, textile auxiliaries, and ion-exchange resins. The bitartrate variant is more specialised for high-purity formulations in cognitive enhancers and skin care products.

Dimethylaminoethanol bitartrate (DMAE bitartrate) market growth is propelled by surging demand in nutraceuticals and cosmetics, where its role as a cognitive enhancer and anti-ageing agent aligns with rising consumer focus on brain health and skin firming properties.

Its pharmaceutical applications, including the synthesis of amino acids and vitamin B derivatives, drive expansion amid personalised medicine trends and nootropic supplement popularity. Additionally, increasing disposable incomes, innovation in high-purity formulations, and steady nutraceutical adoption despite regulatory hurdles on chemical production boost the market growth. However, price volatility from raw material fluctuations, such as precursors like dimethylaminoethanol and tartaric acid, impacts costs and industrial dimethylaminoethanol bitartrate procurement.

Raw Material for Dimethylaminoethanol Bitartrate Production

According to the Dimethylaminoethanol Bitartrate production plant project report, the various raw materials for Dimethylaminoethanol Bitartrate production include dimethylaminoethanol (DMAE) and L-(+)-tartaric acid.

Production Process of Dimethylaminoethanol Bitartrate

The extensive Dimethylaminoethanol Bitartrate production cost report consists of the following major industrial production process:

• Production via acid-base neutralisation: The production process of Dimethylaminoethanol bitartrate occurs via an acid-base neutralisation of dimethylaminoethanol (DMAE) with L-(+)-tartaric acid in a 1:1 molar ratio. The process involves dissolving DMAE in water or ethanol, adding tartaric acid slowly at 20–40 degree Celsius to form the salt. The next step involves stirring for 1–4 hours while adjusting pH to 4–6, cooling to crystallise the product, filtering, washing, and vacuum-drying at 40–60 degree Celsius to achieve >98% purity with yields over 90%.

Properties of Dimethylaminoethanol Bitartrate

Dimethylaminoethanol bitartrate (DMAE bitartrate) is a white to off-white, odourless or faintly odorous crystalline powder with a molecular formula of C8H17NO7 and molecular weight of 239.23 g/mol. It has high water solubility, sparing solubility in ethanol, a melting point of 102–113 degree Celsius, a bulk density of 0.50–0.70 g/mL, and a pH of 3.0–4.0 in 10% aqueous solution. It shows low loss on drying (<0.5%) and minimal residue on ignition (<0.1%). Additionally, as the bitartrate salt of dimethylaminoethanol, it features a protonated tertiary amine and tartaric acid counterion, providing stability for pharmaceutical and cosmetic uses, low toxicity (oral LD50 ~2600 mg/kg in rats), and compliance with purity standards like heavy metals <10 ppm.